Replies to post #439 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

Some interesting tidbits at the end of the press release:

"The new facility will also include the company’s headquarters, discovery research and clinical development. VBL intends to operate and relocate to the new site in the second half of 2017.

VBL said that future commercial supply of VB-111 will likely involve a complementary source of supply, probably via a Contract Manufacturing partner in North America, although those plans have not yet been set."

1) Moving HQ
2) Expanding operations
3) Future NA manufacturing partner

All positive indicators.